Your session is about to expire
← Back to Search
Isoproterenol Exposure Training for Anorexia
Study Summary
This trial is testing if a drug that causes heart and respiratory sensations can help people with anorexia by reducing anxiety around meal times.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 2 trial • 131 Patients • NCT03032965Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Can I qualify to join this experimental research?
"This clinical trial seeks 25 individuals between 18 to 40 years old with a history of anorexia nervosa. Applicants must meet the DSM 5 criteria for Anorexia Nervosa or have an Eating disorder Screen (SCOFF) score ≥ 2 and a body mass index ranging from 17 to 35 kg/m². Selective serotonin reuptake inhibitors and benzodiazepines are accepted, whereas mood stabilizers and antipsychotic medications are not permitted."
Is this research study open to individuals over the age of 20?
"This medical experiment has eligibility criteria requiring participants to be aged between 18 and 40 years old."
To what purpose is Isoproterenol typically deployed?
"Isoproterenol can be administered to treat Brugada Syndrome (BRS), pacemaker-reliance, and Beta Blocker overdose."
How many participants have been recruited for this medical experiment?
"Unfortunately, this specific trial is not in the process of recruiting patients. While it was initially posted on 1/1/2017 and last updated on 4/9/2022, 77 trials for anorexia nervosa and 3 studies related to Isoproterenol are presently enrolling participants."
Is enrollment still open for this medical experiment?
"Data hosted on clinicaltrials.gov suggests that this research is no longer inviting patients to participate. The trial was first posted in January 2017 and its last update occurred on April 9th 2022, but 80 other trials are presently recruiting individuals for their studies."
What aim does this experiment seek to accomplish?
"This trial's primary measure of success is the intensity of sensation reported by participants immediately after drug or placebo infusion. Other metrics, such as Multidimensional Assessment of Interoceptive Awareness (a self-report rating scale), Inventory of Depression and Anxiety (another self-report rating scale), and Anxiety Sensitivity Index (yet another self-report rating scale) are also being tracked."
Have any other investigations been conducted involving Isoproterenol?
"Currently, 3 trials are underway to investigate the efficacy of Isoproterenol with none having reached Phase 3. Of these studies, 4 different trial sites exist in Tulsa, Oklahoma."
Share this study with friends
Copy Link
Messenger